X-67546514-TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC-TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000044.6(AR):c.1415_1420dup(p.Gly472_Gly473dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G456G) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.028 ( 54 hom., 325 hem., cov: 0)
Exomes 𝑓: 0.017 ( 147 hom. 1890 hem. )
Failed GnomAD Quality Control
Consequence
AR
NM_000044.6 inframe_insertion
NM_000044.6 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-67546514-T-TGGCGGC is Benign according to our data. Variant chrX-67546514-T-TGGCGGC is described in ClinVar as [Likely_benign]. Clinvar id is 434265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0285 (2363/83023) while in subpopulation AFR AF= 0.0457 (989/21636). AF 95% confidence interval is 0.0433. There are 54 homozygotes in gnomad4. There are 325 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 54 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AR | NM_000044.6 | c.1415_1420dup | p.Gly472_Gly473dup | inframe_insertion | 1/8 | ENST00000374690.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AR | ENST00000374690.9 | c.1415_1420dup | p.Gly472_Gly473dup | inframe_insertion | 1/8 | 1 | NM_000044.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0284 AC: 2360AN: 83019Hom.: 54 Cov.: 0 AF XY: 0.0196 AC XY: 325AN XY: 16609
GnomAD3 genomes
AF:
AC:
2360
AN:
83019
Hom.:
Cov.:
0
AF XY:
AC XY:
325
AN XY:
16609
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0170 AC: 8096AN: 475254Hom.: 147 Cov.: 25 AF XY: 0.0161 AC XY: 1890AN XY: 117724
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
8096
AN:
475254
Hom.:
Cov.:
25
AF XY:
AC XY:
1890
AN XY:
117724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0285 AC: 2363AN: 83023Hom.: 54 Cov.: 0 AF XY: 0.0196 AC XY: 325AN XY: 16619
GnomAD4 genome
AF:
AC:
2363
AN:
83023
Hom.:
Cov.:
0
AF XY:
AC XY:
325
AN XY:
16619
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 04, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 14, 2024 | Variant summary: AR c.1415_1420dupGCGGCG (p.Gly472_Gly473dup) results in an in-frame duplication that is predicted to duplicate two amino acids into the encoded protein. The variant allele was found at a frequency of 0.019 in 558277 control chromosomes in the gnomAD database, including 201 homozygotes. The observed variant frequency is above the estimated maximal expected allele frequency for a pathogenic variant in AR causing Androgen Resistance Syndrome strongly suggesting that the variant is benign. c.1415_1420dupGCGGCG has been reported in the literature in an individual affected with Androgen Resistance Syndrome (Wu_2018). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 29693241). ClinVar contains an entry for this variant (Variation ID: 434265). Based on the evidence outlined above, the variant was classified as benign. - |
Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | AR: BS1, BS2 - |
Androgen resistance syndrome;C0268301:Partial androgen insensitivity syndrome;C0376358:Malignant tumor of prostate;C1839259:Kennedy disease;C2678098:Hypospadias 1, X-linked Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 14, 2022 | - - |
AR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 19, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at